Pharma’s Embarrassing Placebo Problem To get a drug approved, drug companies only need to show it works better than a placebo. Shouldn't the bar be higher?

Pharma’s Embarrassing Placebo Problem www.peoplespharmacy.com/articles/pha... via @peoplespharmacy

#placebo #pharma #pharmaresearch #medications #Rx #health

SPER PharmaMed AI – Pharmaceutical AI Analytics Platform PharmaMed AI is an AI-powered pharmaceutical market intelligence platform for market analysis, business intelligence, competitive research, and forecasting.

An AI platform for pharma market research is redefining how companies analyze disease landscapes, competitors, and market opportunities.

From insights to strategy—make data-driven decisions with confidence.
Learn more: www.sperresearch.com/pharmamedai

#PharmaResearch #ArtificialIntelligence

COPS DSU hosted a DBT-supported lecture on Drug Discovery innovations on March 6. Experts shared insights on Alzheimer’s, cancer research, and bacteriophages.

Supercharging India’s AI future with DSU. India’s AI-First University.

#DSU #PharmaResearch

REJURAN COSMETICS Expands U.S. Presence with Sephora Launch in 2026 REJURAN COSMETICS debuts at Sephora, showcasing its medical aesthetic skincare products in stores and online across the U.S. market.

REJURAN COSMETICS Expands U.S. Presence with Sephora Launch in 2026 #United_States #Los_Angeles #Sephora #Rejuran #PharmaResearch

genomirx.com/synthesis-pa...
Genomirx Chemicals, (S)-(+)-2,3,7,7a-Tetrahydro-7a-methyl-1H-indene-1,5(6H)-dione, 90% AC296470050 @genomirx #chmicals #tetrahdro #methyl #indene #dione #OrganicChemistry #ChiralCompound
#AsymmetricSynthesis #ChemicalIntermediate
#ResearchChemicals #PharmaResearch

Innovation is in our DNA. From formulation science to advanced drug delivery systems, Hab Pharma continues to push boundaries in pharma research.
#HabPharma #Innovation #PharmaResearch #FutureOfHealthcare

US Chromatography Reagents Market Size, Growth Insights 2035 The US Chromatography Reagents Market Industry is expected to grow from 1.32(USD Billion) in 2024 to 2.9 (USD Billion) by 2035.

The US Chromatography Reagents Market is expanding with rising pharmaceutical & biotech research activities. Explore insights: www.marketresearchfuture.com/reports/us-c...
#PharmaResearch #Chromatography

US Chiral Chromatography Columns Market Size, Growth - 2035 US Chiral Chromatography Columns Market share register 750 USD Million in 2024, projected to grow 4.75 % CAGR to reach USD Million 1250 during the forecast period 2025 - 2035.

Advancements in pharma research drive the US Chiral Chromatography Columns Market. Full report: www.marketresearchfuture.com/reports/us-c...
#PharmaResearch #Chromatography

US Cell Viability Assays Market Size, Industry Growth 2035 US Cell Viability Assays Market share register 625.84 USD Million in 2024, projected to grow 8.50% CAGR to reach USD Million 1535.60 during the forecast period 2025 - 2035.

Drug discovery demand strengthens the US Cell Viability Assays Market. Learn more: www.marketresearchfuture.com/reports/us-c...
#PharmaResearch #Biotech

PharmaResearch Ventures into Brazilian Aesthetic Market with Exclusive Rejuran Supply Agreement PharmaResearch has secured an exclusive supply agreement for Rejuran in Brazil with DermaDream, targeting the growing aesthetic market.

PharmaResearch Ventures into Brazilian Aesthetic Market with Exclusive Rejuran Supply Agreement #None #Brazil #Rejuran #PharmaResearch #DermaDream

PharmaResearch Secures FDA Approval to Launch Phase 1 Trial for Innovative Nano Anticancer Drug PRD-101 PharmaResearch has received FDA clearance to begin Phase 1 trials for PRD-101, a promising nano anticancer drug, targeting advanced solid tumors.

PharmaResearch Secures FDA Approval to Launch Phase 1 Trial for Innovative Nano Anticancer Drug PRD-101 #USA #California #FDA_Approval #PharmaResearch #PRD-101

ADME Toxicology Testing Market Size, Share, Report 2033 The global ADME toxicology testing market size reached USD 10.3 Billion in 2024 and expected to hit USD 30.2 Billion by 2033, at a CAGR of 11.32%.

🧪 ADME Toxicology Testing Market Set for Rapid Growth! 📈

The global market was valued at USD 10.3 Billion in 2024 and is projected to reach USD 30.2 Billion by 2033, growing at a CAGR of 11.32%. 🌍🔬

🔗 www.imarcgroup.com/adme-toxicol...

#ADMEToxicology #DrugDiscovery #MedTech #PharmaResearch

Enzyme Inhibitors Market Size, Growth, Trends, Report 2035 Enzyme Inhibitors Market growth is projected to reach USD 45.31 Billion, at a 5.37% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2025 to 20...

🧬 Drug discovery advances expand the Enzyme Inhibitors Market. 📈 www.marketresearchfuture.com/reports/enzy... #PharmaResearch

Fucosidosis Therapeutic Market Size, Growth Report 2035 Fucosidosis Therapeutic Market growth is projected to reach USD 570.26 Billion, at 8.82% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2025 ...

Discover Fucosidosis Therapeutic Market forecast & key trends. Explore growth opportunities: www.marketresearchfuture.com/reports/fuco... #PharmaResearch #MarketInsights

Histone Deacetylase Inhibitor Market Size, Share, Report 2035 Histone Deacetylase Inhibitor Market share is projected to reach USD 11.35 Billion By 2035, at a 7.16 % CAGR by driving industry size, top company analysis, segments research, trends and forecast repo...

Explore the Histone Deacetylase Inhibitor Market growth & trends. Key insights for pharmaceutical innovation: www.marketresearchfuture.com/reports/hist... #PharmaResearch #MarketTrends

Exploring collaborations for two early-stage deep-tech projects: a neuromorphic photonic architecture and a green, natural-sourced pharma synthesis platform. Seeking teams or funds open to cooperation or infrastructure support. DM open.

#ai #neurotech #greenchemistry #pharmaresearch

J＆J、早期アルツハイマー病を対象としたAuτonomy試験を中止 主要評価項目に統計的有意差届かず | STELLANEWS.LIFE Johnson ＆ Johnsonは、posdinemabによる精密介入を検証するAuτonomy試験を中止。早期アルツハイマー病に対する概念検証試験で統計的有意差を達成できず。得られる分析は今後の研究に活用予定。

J&J Halts Early Alzheimer’s Disease Study “Auτonomy” After Missing Primary Endpoint

🔗 Full article: stellanews.life/technology_c...

#JohnsonandJohnson #Alzheimers #ClinicalTrials #Neuroscience #PharmaResearch #Neurodegeneration #PrecisionMedicine #R&D

3D Cell Culture Market Size to Surpass USD 3.94 Billion by 2030 at 14.90% CAGR – Report by Market Research Future (MRFR) 3D Cell Culture Market Trends And Insights by Technique (Scaffolds Based 3D Cell Culture [Hydrogel-Based Support and Polymeric Hard Material Based Support]...

🧬 3D Cell Culture Market to hit USD 3.94B by 2030 at 14.90% CAGR! Transforming drug discovery & tissue engineering. 🔬
🔗 www.globenewswire.com/en/news-rele...
#CellCulture #Biotech #PharmaResearch

“Hit discovery” may sound simple, but it’s the foundation of every modern medicine.
Explore why this stage determines success or failure in drug innovation.
👉 youtu.be/SLS2C6uPxSA

#PharmaResearch #MedicalInnovation #SkyHealthAcademy

Separation Systems for Commercial Biotechnology Market Size, Growth Outlook 2035 Separation Systems for Commercial Biotechnology Market growth is projected to reach 15.4 USD billion, at a 4.87% CAGR by driving industry size, share, top company analysis, segments research, trends a...

🧫 The Separation Systems Market surges with growing biopharma R&D and protein purification demand. Report: www.marketresearchfuture.com/reports/sepa... #Biotech #PharmaResearch #LabEquipment

Nerve Monitoring System Market Size, Growth, Trends 2035 Supercritical Fluid Chromatography Market Industry is expected to grow from 0.75(USD Billion) in 2024 to 1.2 (USD Billion) by 2035. Supercritical Fluid Chromatography Market CAGR (growth rate) is expe...

⚗️ The Supercritical Fluid Chromatography Market expands with greener, faster analytical technologies. Full report: www.marketresearchfuture.com/reports/supe... #Chromatography #LabTechnology #PharmaResearch

EZH2 Inhibitors Market Size, Share, Growth Report 2035 EZH2 Inhibitors Market growth is projected to reach USD 9.59 Billion, at a 13.88% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2025 to 2035

🧫 The EZH2 Inhibitors Market expands as epigenetic therapy reshapes oncology drug development. Explore: www.marketresearchfuture.com/reports/ezh2... #CancerTherapy #PharmaResearch #Oncology

Lysosomal Acid Lipase Deficiency Market Size, Report 2035 Lysosomal Acid Lipase Deficiency Market to reach USD 2.64 Billion by 2035, growing at 9.72% CAGR. Explore size, share, companies, segments & forecast 2025–2035.

🧬 The LAL Deficiency Market evolves with breakthroughs in enzyme replacement therapies. Full study: www.marketresearchfuture.com/reports/lyso... #RareDisease #GeneticTherapy #PharmaResearch

Hereditary Multiple Exostoses Treatment Market By 2035 Hereditary Multiple Exostoses Treatment Market growth is projected to reach USD 1.40Billion, at a 5.48% CAGR by driving industry size, share, top company analysis, segments research, trends and foreca...

🧠 The HME Treatment Market expands as research in rare bone disorders and gene therapy advances. Learn more: www.marketresearchfuture.com/reports/here... #RareDisease #GeneticDisorders #PharmaResearch

GM1 Gangliosidosis Market Size, Trends, Growth Report 2035|MRFR GM1 Gangliosidosis Market growth is projected to reach USD 1.5 Billion, at a 11.85% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2024 to 20...

🧬 The GM1 Gangliosidosis Market evolves as rare disease research & gene therapy progress accelerate hope. Report: www.marketresearchfuture.com/reports/gm1-... #RareDisease #GeneTherapy #PharmaResearch

Becker Muscular Dystrophy Treatment Market Report 2035 Becker Muscular Dystrophy Treatment Market growth is projected to reach USD 3.47 Billion, at a 11.6% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast ...

🧬 Hope through science! The Becker Muscular Dystrophy Treatment Market grows with gene therapy breakthroughs. Report: www.marketresearchfuture.com/reports/beck... #MuscularDystrophy #RareDisease #PharmaResearch

Brown-Sequard Syndrome Treatment Market Growth Report 2035 Brown-Sequard Syndrome Treatment Market growth is projected to reach USD 288.57 Billion, at a 5.16% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast r...

🧠 The Brown-Sequard Syndrome Treatment Market expands as neurology research accelerates therapy development. Explore: www.marketresearchfuture.com/reports/brow... #Neurology #RareDiseases #PharmaResearch

Pulmonary Embolism Therapeutics Market Size, Growth By 2035 Pulmonary Embolism Therapeutics Market growth is projected to reach USD 2.26 Billion, at a 5.92% CAGR by driving industry, top company analysis, segments research, trends and forecast report 2025 to 2...

🫁 Life-saving innovation! The Pulmonary Embolism Therapeutics Market expands with novel drugs & rapid diagnosis solutions. Details: www.marketresearchfuture.com/reports/pulm... #Cardiology #PulmonaryCare #PharmaResearch

Europe CRO Market Size, Growth, Trends, Report 2035 Europe CRO Market size is projected to register a CAGR of 6.80% to reach USD 44.49 Billion by 2035, Europe CRO industry analysis by Service Type, Application and End-user

🧬 Europe’s CRO Market grows as clinical research outsourcing rises amid pharma innovation. Explore key trends: www.marketresearchfuture.com/reports/euro... #CRO #PharmaResearch #LifeSciences